BELVIN MARCIA sold CTMX
March 19, 2024 · Form 4 insider transaction
BELVIN MARCIA sold 12,795 shares of CytomX Therapeutics, Inc. at $2.09 per share, a transaction worth $26.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,795
Price
$2.09
Total value
$26.7K
InsiderBELVIN MARCIA
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 19, 2024
Filing dateMarch 21, 2024
Shares owned after168,579
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.; Includes 109,166 restricted stock units.